DexCom enters $500M accelerated share repurchase with Bank of America

DEXCOM INC

ASR agreement with BofA for up to $500M; initial payment of $500M made October 31, 2023.
Received initial delivery of ~4.7 million shares of common stock on same date.
Final settlement expected in Q4 2023 based on volume-weighted average price less discount.
Repurchase executed under existing $500M buyback program authorizing repurchases through October 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.